| 6-PN | 6-prenylnaringenin |
| 8-PN | (±)-8-prenylnaringenin |
| A-2780 cells | Ovarian cancer cells |
| ABTS | 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid |
| AE | Association Efficiency |
| AFM | Atomic Force Spectroscopy |
| AMPK | AMP-activated protein kinase |
| ASDs | Amorphous solid dispersions |
| b.w. | Body weight |
| B16F10 cells | Malignant cutaneous melanoma cells |
| BSEP | Bile salt export pump |
| BVDV | Bovine viral diarrhoea virus |
| Caco-2 cells | Human colorectal adenocarcinoma cells |
| CCD | Central Composite Design |
| CD | Crohn’s disease |
| CMV | Herpesviruses cytomegalovirus |
| CNP | Nanochitosan |
| COVID-19 | Coronavirus disease 2019 |
| CPE | Cytopathic effects |
| CRP | C-reactive protein |
| CS | Chitosan |
| DDSs | Drug Delivery Systems |
| DMX | Desmethylxanthohumol |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl |
| DSC | Differential Scanning Calorimetry |
| EE | Entrapment Efficiency |
| FTIR | Fourier Transform Infrared Spectroscopy |
| FXR | Farnesoid X receptor |
| GMS | Glyceryl monostearate |
| HaCaT | Human keratinocytes |
| HA-g-PLLA | Hydroxyapatite-grafted poly(L-lactic acid) |
| HCE-T cells | Human corneal epithelial cells |
| HEM-DP | Human melanocytes from darkly pigmented skin |
| HRV | Human rhinovirus |
| HSV-1 | Herpes simplex virus type 1 |
| HSV-2 | Herpes simplex virus type 2 |
| HT-29 cells | Human colon cancer cells |
| i.p. | Intraperitoneal |
| i.v. | Intravenous |
| IC50 | Half-maximal inhibitory concentrations |
| ICU | Intensive care unit |
| IL-12 | Interleukin-12 |
| IX | Isoxanthohumol |
| LPS | Lipopolysaccharide |
| MCF-7 cells | Human breast cancer cells |
| MCT | Medium-chain triglyceride |
| ME | Microemulsion |
| MIC | Minimal inhibitory concentration |
| MMPs | Matrix metalloproteinases |
| M n | Average molecular weight |
| Mpro | Main protease |
| MRC-5 | Human lung fibroblast cells |
| NFκB | Nuclear factor-kappa B |
| NLR | Neutrophil-to-lymphocyte ratio |
| NPs | Nanoparticles |
| NRF2 | Nuclear factor erythroid 2 |
| OLN-93 | Oligodendroglia-derived cells |
| PAMs | Primary alveolar macrophages |
| PBMCs | Peripheral blood mononuclear cells |
| PC12 cells | Pheochromocytoma cells |
| PCL | Poly(ε-caprolactone) |
| PCR-DGGE | Polymerase chain reaction denaturing gradient gel electrophoresis |
| PDDSs | Polymer Drug Delivery Systems |
| PEO | Polyethylene oxide |
| PGA | Poly(glycolic acid) |
| PK | Pharmacokinetics |
| PLA | Poly(lactic acid) |
| PLACL | Poly(lactic acid-co-ε-caprolactone) |
| PLCγ2 | Phosphorylation of phospholipase Cγ2 |
| PLGA | Poly(lactic-co-glycolic acid) |
| PLR | Platelet-to-lymphocyte ratio |
| PPO | Polypropylene oxide |
| PRRSV | Porcine reproductive and respiratory syndrome viruses |
| PZ | Serpin-like protein Z |
| RAW264.7 cells | Macrophagic mouse cells |
| RES | Resveratrol |
| ROS | Reactive Oxygen Species |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| SD | Sprague Dawley |
| SLNs | Solid lipid nanoparticles |
| SLs | Sophorolipids |
| SR | Sarcoplasmic Reticulum |
| S-SNEDDS | Solid Self-Nanoemulsifying Drug Delivery System |
| T2DM | Type 2 diabetes mellitus |
| TI | Therapeutic index |
| UC | Ulcerative colitis |
| US FDA | US Food and Drug Administration |
| XG | Xanthogalenol |
| Xn | Xanthohumol |
| XnC | Xanthohumol C |
| X-ray Diffraction | X-ray Diffraction |
| ζ | Zeta potential |